CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemothe ...
Phase 2
Kansas City, Kansas, United States and 8 other locations
Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNB ...
Phase 1, Phase 2
Kansas City, Kansas, United States and 6 other locations
(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...
Phase 1, Phase 2
Westwood, Kansas, United States and 15 other locations
and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...
Phase 2, Phase 3
Kansas City, Missouri, United States and 294 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...
Phase 3
Kansas City, Kansas, United States and 506 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Westwood, Kansas, United States and 275 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Westwood, Kansas, United States and 258 other locations
in participants with solid tumors.Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be remov...
Phase 1, Phase 2
Westwood, Kansas, United States and 65 other locations
The goal of the Dose Escalation phase of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity...
Phase 1
Fairway, Kansas, United States and 18 other locations
This is a first-in-human Phase 1b, 2-part, multicenter open-label clinical study to evaluate safety and efficacy of a Nectin-4 radiopharmaceutical (\...
Phase 1
Westwood, Kansas, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal